Demeterherb touts TÜV Rheinland-certified NMN manufacturing in China
Demeterherb says its NMN powder program combines a 99% HPLC specification, lot-level documentation and TÜV Rheinland Factory Certification for buyers evaluating ingredient quality and factory credentials. The company is pitching the setup to nutraceutical and food brands that need traceable supply, private-label support and cross-border logistics.
Why it matters: - NMN buyers often need two separate checks: a qualified factory and a batch that matches the specification. - Demeterherb is positioning itself as a supplier that provides both factory-level verification and lot-level documentation. - The setup is aimed at brands that need traceable raw material sourcing for capsules, tablets, powders and blended products.
What happened: - Xi'an Demeter Biotech Co., Ltd., which operates under the Demeterherb brand, says it offers Beta-Nicotinamide Mononucleotide at a 99% specification. - The company says the material is tested by HPLC and identified with CAS 1094-61-7. - Demeterherb says its factory has TÜV Rheinland Factory Certification. - The company says it serves pharmaceutical, nutraceutical, nutrition supplement, functional food and functional beverage customers. - Demeterherb says its supply reaches more than 50 countries and regions. - The company says it also offers Liposomal NMN at 50% and 70%.
The details: - Demeterherb says buyers can request free samples and certificates of analysis. - The company says its NMN products have a 24-month shelf life. - Demeterherb says its quality-system credentials include ISO22000, HACCP, HALAL and Kosher. - The company says EU or NOP organic certification is not used to define its NMN grades. - Demeterherb says private-label services include hard capsules, soft capsules, tablets, granules and customized packaging. - The company says shipping options include express, air, sea, railway and truck. - Demeterherb says it has independent import and export rights and multi-modal logistics support. - The company says customers should keep lot number, production date, packaging format, storage requirement and released specification with each order. - Demeterherb says purchase records should distinguish 99% NMN powder from 50% or 70% Liposomal NMN. - The company says the approved sample should match the commercial lot on identity, assay basis, test method, appearance, packaging and storage conditions.
Between the lines: - The pitch centers on evidence chain, not product hype. - Factory certification and batch testing solve different problems, and Demeterherb is trying to address both in one supplier review process. - That approach is meant to help procurement, quality and formulation teams avoid substitutions during scale-up and repeat orders. - The company’s messaging avoids disease, anti-aging or guaranteed-outcome claims and stays on documentation, traceability and supply execution.
What's next: - Demeterherb says procurement and product-development teams can request the current NMN specification, COA, factory qualification documents, samples, packaging options, private-label plan and quotation at the company’s website. - The company says repeat orders should be reviewed for any change in assay basis, analytical method, appearance, package closure, storage instruction or label data before production. - Demeterherb says the goal is recurring supply that preserves the same NMN identity from sample approval to finished delivery.
The bottom line: - Demeterherb is selling NMN as a documentation-first ingredient business, with TÜV Rheinland certification, HPLC testing and traceable lots as the core sales pitch.
Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.
Sign up for:
Asia Healthcare Industry Digest
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.